Sexually Transmitted Diseases

  • Donald R. Koester
  • John G. Ryan
  • Grant Fowler


As recently as the mid-1980s, epidemiologic evidence suggested that the incidence of major sexually transmitted diseases (STDs) was decreasing. During following years, however, it became clear that the incidence of major STDs was decreasing in some risk groups while dramatically increasing in others. For example, the incidence of primary and secondary syphilis decreased by 69% among non-Hispanic men between 1982 and 19891 and by 30% among African American men between 1982 and 1985.2 However, this trend reversed in 1986, with the incidence of syphilis increasing by 25% for both African Americans and Hispanics.2 Major STDs that are renewing their threats to population groups at increased risk include gonorrhea, hepatitis B virus, and genital warts caused by the human papillomavirus. Herpes also remains a significant condition that family physicians continue to encounter. Chlamydia infection, thought to be the most common STD and endemic to all sociodemographic population groups, causes significant morbidity.3,4 An insidious recurrent theme among these diseases is that simultaneous infection with more than one STD occurs frequently.3


Human Immunodeficiency Virus Infection Pelvic Inflammatory Disease Genital Wart Genital Herpes Chlamydial Infection 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Rolfs RT, Nakashima AK. Epidemiology of primary and secondary syphilis in the United States, 1981 through 1989. JAMA 1990;264: 1432–7.PubMedCrossRefGoogle Scholar
  2. 2.
    Centers for Disease Control. Syphilis and congenital syphilis— United States, 1985–1988. MMWR 1988;37:486–9.Google Scholar
  3. 3.
    Handsfield HH. Recent developments in STDs. I. Bacterial diseases. Hosp Pract (Off Ed) 1991;26:47–56.Google Scholar
  4. 4.
    Washington AE, Johnson RE, Sanders LL. Chlamydia trachomatis infections in the United States. What are they costing us? JAMA 1987;257:2070–2.PubMedCrossRefGoogle Scholar
  5. 5.
    Christmas JT, Wendel GD, Bawdon RE, Farris R, Cartwright G, Little BB. Concomitant infection with Neisseria gonorrhoeae and Chlamydia trachomatis in pregnancy. Obstet Gynecol 1989;74: 295–8.PubMedGoogle Scholar
  6. 6.
    Cates W Jr, Hinman AR. Sexually transmitted diseases in the 1990s [editorial]. N Engl J Med 1991;352:1368–70.CrossRefGoogle Scholar
  7. 7.
    Wasserheit JN. Epidemiological synergy: interrelationships between HIV infection and other STDs. In: Chen L, Sepulveda J, Segal S, editors. AIDS and women’s health: science for policy and action. New York: Plenum Press, 1992.Google Scholar
  8. 8.
    Goldsmith ME “Silent epidemic” of “social disease” makes STD experts raise their voices [news]. JAMA 1989;261:3509–10.PubMedCrossRefGoogle Scholar
  9. 9.
    Handsfield HH, Jasman LL, Roberts PL, Hanson VW, Kothen-beutel RL, Stamm WE. Criteria for selective screening for Chlamydia trachomatis infection in women attending family planning clinics. JAMA 1986;255:1730–4.PubMedCrossRefGoogle Scholar
  10. 10.
    Pruessner HT, Hansel NK, Griffiths M. Diagnosis and treatment of chlamydial infections. Am Fam Physician 1986;34:81–92.PubMedGoogle Scholar
  11. 11.
    Shafer MA, Schachter J, Moscicki AB, et al. Urinary leukocyte esterase screening test for asymptomatic chlamydial and gonococcal infections in males. JAMA 1989;262:2562–6.PubMedCrossRefGoogle Scholar
  12. 12.
    Centers for Disease Control. 1989 Sexually transmitted diseases treatment guidelines. MMWR 1989;38 Suppl 8:1–43.Google Scholar
  13. 13.
    Batteiger BE, Jones RB, White A. Efficacy and safety of ofloxacin in the treatment of nongonococcal sexually transmitted disease. Am J Med 1989;87(6c):75S-77S.Google Scholar
  14. 14.
    Stamm WE. Azithromycin in the treatment of uncomplicated genital chlamydial infections. Am J Med 1991;91(3a):19S-22S.CrossRefGoogle Scholar
  15. 15.
    Handsfield HH. Sexually transmitted diseases. Hosp Pract (Off Ed) 1982;17:99–116.Google Scholar
  16. 16.
    Felman YM, Nikitas JA. Anorectal gonococcal infection. NY State J Med 1980;80:231–3.Google Scholar
  17. 17.
    Holmes KK, Handsfield HH. Sexually transmitted diseases. In: Braunwald E, Isselbacher KJ, Petersdorf RG, et al., editors. Harrison’s principles of internal medicine. New York: McGraw-Hill, 1987:506–18.Google Scholar
  18. 18.
    Embree J, Caliando JJ, McCormack WM. Nonspecific vaginitis among women attending a sexually transmitted diseases clinic. Sex Transm Dis 1984;11:81–84.PubMedCrossRefGoogle Scholar
  19. 19.
    Wiesner PJ. Gonorrhea. Cutis 1981;27:249–54.PubMedGoogle Scholar
  20. 20.
    Handsfield HH. Nongonococcal urethritis. Cutis 1981;27:268–77.PubMedGoogle Scholar
  21. 21.
    Handsfield HH, McCormack WM, Hook JM III, et al. A comparison of single dose Cefixime with ceftriaxone as treatment for uncomplicated gonorrhea. N Engl J Med 1991;325:1337–41.PubMedCrossRefGoogle Scholar
  22. 22.
    Jacobson L, Westrom L. Objectivized diagnosis of acute pelvic inflammatory disease: diagnostic and prognostic value of routine laparoscopy. Am J Obstet Gynecol 1969;105:1088–98.PubMedGoogle Scholar
  23. 23.
    Hadgu A, Westrom L, Brooks CA, Reynolds GH, Thompson SE. Predicting acute pelvic inflammatory disease: a multivariate analysis. Am J Obstet Gynecol 1986;155:954–960.PubMedGoogle Scholar
  24. 24.
    Hook EW, Marra CM. Acquired syphilis in adults. N Engl J Med 1992;326:1060–9.PubMedCrossRefGoogle Scholar
  25. 25.
    Simonsen JN, Cameron DW, Gakinya MN, et al. Human immunodeficiency virus infection among men with sexually transmitted diseases: experience from a center in Africa. N Engl J Med 1988;319:274–8.PubMedCrossRefGoogle Scholar
  26. 26.
    Fitzgerald F. The great imitator, syphilis. West J Med 1981;134: 424–32.PubMedGoogle Scholar
  27. 27.
    Bowie WR, MacDonald NE. Canadian guidelines for the diagnosis and management of sexually transmitted diseases by syndrome, in children, adolescents, and adults. CDWR 1989;March: 12–23.Google Scholar
  28. 28.
    Romanowski B, Sutherland R, Fick GH, Mooney D, Love EJ. Serologic response to treatment of infectious syphilis. Ann Intern Med 1991;114:1005–9.PubMedCrossRefGoogle Scholar
  29. 29.
    Nuovo GJ, Pedemonte BM. Human papillomavirus types and recurrent cervical warts. JAMA 1990;263:1223–6.PubMedCrossRefGoogle Scholar
  30. 30.
    Kiviat NB, Koutsky LA, Paavonen JA, et al. Prevalence of genital papillomavirus infection among women attending a college student health clinic or a sexually transmitted disease clinic. J Infect Dis 1989;87:11S-13S.Google Scholar
  31. 31.
    Cripe TP. Human papillomaviruses: pediatric perspectives on a family of multifaceted tumorigenic pathogens. Pediatr Infect Dis J 1990;9:836–44.PubMedCrossRefGoogle Scholar
  32. 32.
    Margolis S. Genital warts and molluscum contagiosum. Urol Clin North Am 1984;11:163–70.PubMedGoogle Scholar
  33. 33.
    Lynch PJ. Condylomata acuminata (anogenital warts). Clin Obstet Gynecol 1985;28:142–51.PubMedCrossRefGoogle Scholar
  34. 34.
    Campion MJ. Clinical manifestations and natural history of genital human papillomavirus infection. Obstet Gynecol Clin North Am 1987;14:363–88.PubMedGoogle Scholar
  35. 35.
    Koutsky LA, Wolner Hanssen P. Genital papillomavirus infections: current knowledge and future prospects. Obstet Gynecol Clin North Am 1989;16:541–64.PubMedGoogle Scholar
  36. 36.
    Fiumara NJ, Wagner RE Perianal Bowen’s disease associated with anorectal warts: a case report. Sex Transm Dis 1987;14:58–60.PubMedCrossRefGoogle Scholar
  37. 37.
    Reichman RC. Human papillomaviruses and interferon therapy. In: Galasso GJ, Whitely RJ, Merigan TC, editors. Antiviral agents and viral diseases of man. New York: Raven Press, 1990:301–25.Google Scholar
  38. 38.
    Zazove P, Caruthers BS, Reed BD. Genital human papillomavirus infection. Am Fam Physician 1991;43:143–8.Google Scholar
  39. 39.
    Rapini RR Veneral warts. Prim Care 1990;17:127–144.PubMedGoogle Scholar
  40. 40.
    Krebs HB. Management of human papillomavirus-associated genital lesions in men. Obstet Gynecol 1989;73:312–16.PubMedGoogle Scholar
  41. 41.
    Baker DA, Douglas JM, Buntin DM, Micha JP, Beutner KR, Pats-ner B. Topical podofilox for the treatment of condylmata acuminata in women. Obstet Gynecol 1990;76:656–61.PubMedGoogle Scholar
  42. 42.
    Paavonen J. Subcutaneous interferon alpha in the treatment of refractory condylomata. Sex Transm Dis 1990;17:152–3.PubMedCrossRefGoogle Scholar
  43. 43.
    Stone KM, Becker TM, Hadgu A, Kraus SJ. Treatment of external genital warts: a randomised clinical trial comparing podophyllin, cryotherapy, and electrodesiccation. Genitourin Med 1990;66:16–19.PubMedGoogle Scholar
  44. 44.
    Tong MJ. Hepatitis B vaccination of neonates and children. Am J Med 1989;87:33S-35S.CrossRefGoogle Scholar
  45. 45.
    Kane MA, Alter MJ, Hadler SC, Margolis HS. Hepatitis B infection in the United States: recent trends and future strategies for control. Am J Med 1989;87:11S-13S.CrossRefGoogle Scholar
  46. 46.
    Alter MJ, Hadler SC, Margolis HS, et al. The changing epidemiology of hepatitis B in the United States: need for alternative vaccination strategies. JAMA 1990;263:1218–22.PubMedCrossRefGoogle Scholar
  47. 47.
    Alter MJ, Coleman PJ, Alexander WJ, et al. Importance of heterosexual activity in the transmission of hepatitis B and non-A, non-B hepatitis. JAMA 1989;262:1201–5.PubMedCrossRefGoogle Scholar
  48. 48.
    Felman YM, Nikitas JA. Sexually transmitted viral hepatitis. NY State J Med 1980;80:64–66.Google Scholar
  49. 49.
    Hoofnagle JH, Di Bisceglie AM. Antiviral therapy of viral hepatitis. In: Galasso GJ, Whitely RJ, Merigan TC, editors. Antiviral agents and viral diseases of man. New York: Raven Press, 1990: 415–60.Google Scholar
  50. 50.
    Sever JL, Nerurkar LS. Diagnosis of herpes simplex. Ann Intern Med 1986;34:127–32.Google Scholar
  51. 51.
    Miller RG, Whittington WL, Coleman RM, Nigida SM. Acquisition of concomitant oral and genital infection with herpes simplex virus type 2. Sex Transm Dis 1987;14:41–43.PubMedCrossRefGoogle Scholar
  52. 52.
    Brock BV, Selke S, Benedetti J, Douglas JM, Corey L. Frequency of asymptomatic shedding of herpes simplex virus in women with genital herpes. JAMA 1990;263:418–20.PubMedCrossRefGoogle Scholar
  53. 53.
    Stenzel-Poore MP, Hallick LM, Fendrick JL, Neuburg M, Storrs FJ, Hanifin JM. Herpes simplex virus shedding in genital secretions. Sex Transm Dis 1987;14:17–22.PubMedCrossRefGoogle Scholar
  54. 54.
    Corey L, Holmes KK. Genital herpes simplex virus infections: current concepts in diagnosis, therapy, and prevention. Ann Intern Med 1983;98:973–83.PubMedCrossRefGoogle Scholar
  55. 55.
    Corey L, Adams HG, Brown ZA, Holmes KK. Genital herpes simplex virus infections: clinical manifestations, course, and complications. Ann Intern Med 1983;98:958–72.PubMedCrossRefGoogle Scholar
  56. 56.
    Swinker ML. Clinical aspects of genital herpes. Am Fam Physician 1986;34:127–32.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1994

Authors and Affiliations

  • Donald R. Koester
  • John G. Ryan
  • Grant Fowler

There are no affiliations available

Personalised recommendations